
David Pascoe
David Pascoe started the Rosacea Support Group in October 1998.
A clinical trial supported by Galderma is to be conducted at UCSD to determine via changes in inflammatory markers, how Ivermectin works to relieve rosacea symptoms. After 12 weeks participants will be examined to determine changes in serine protease activity and expression of cathelicidin (LL-37) mRNA. Any changes found in these inflammatory markers will be correlated […]
Continue Reading
Rosacea News is featuring series of articles that I’m calling “My Rosacea Story“. There is real power in hearing other people’s stories. We’d love to hear from you too. Feel free to send me an email, and to use the following questions as a starting point. Thanks to Jennifer for sharing. How long ago, and […]
Continue Reading
Rosacea News is featuring series of articles that I’m calling “My Rosacea Story“. There is real power in hearing other people’s stories. We’d love to hear from you too. Feel free to send me an email, and to use the following questions as a starting point. Thanks to Trish for sharing. How long ago, and […]
Continue Reading
Rosacea News is featuring a series of articles that I’m calling “My Rosacea Story“. There is real power in hearing other people’s stories. We’d love to hear from you too. Feel free to send me an email, and to use the following questions as a starting point. Thanks to Terry for sharing. How long ago, […]
Continue Reading
A paper in the Journal of Drugs in Dermatology is detailing a case report where rebound associated with Mirvaso occured after 2 years of otherwise successful use. The patient was enjoying the benefits of Mirvaso – a blanching of their erythema, for 2 years when they unexpectedly experienced rebound redness. The patient noted that Mirvaso […]
Continue Reading